| Name | Title | Contact Details |
|---|
Paradigm Capital Inc. is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Delta Health Technologies is a Altoona, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sanomedics International Holdings, Inc. (SIMH) manufactures and distributes innovative professional medical, as well as, home health diagnostic devices and products.
Unity Health System is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Unity Health System is based in Rochester, NY. You can find more information on Unity Health System at www.unityhealth.org
DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.